Safety of CRIS100 on Treatment Spinal Cord Injury

Drug
General health
Online since 30 December 2023, updated 62 days ago

About this trial

The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are: safety of CRIS100 efficacy of CRIS100 P...

Included participants

Gender
All
Age
18 - 70 years
Injury level
T2 - T10
  • Severity (AIS)?
  • AIS-A
    Time since injury
    ≤ 72 null
    Healthy volunteers
    No
    T2-T10

    What’s involved

    Type

    Drug

    Details

    Participants with complete spinal cord injury between T2 and T10 (ASIA A, according to ISNCSCI, 2019 revision) and: occurred less than 72 hours ago with surgical indication bulbocavernous reflex present who can receive treatment with CRIS100 within 72 hours after the trauma (preferably within 24 hours)

    Potential benefits

    Main benefits

    General health

    Additional benefits

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Recruiting soon
    • Trial start date
    • 15 May 2023
    • Organisation
    • Cristália Produtos Químicos Farmacêuticos Ltda.
    • Trial recruitment status
    • Recruiting soon
    • Trial start date
    • 15 May 2023
    • Organisation
    • Cristália Produtos Químicos Farmacêuticos Ltda.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more